HMG-CoA Reductase Inhibitors (Statins)
Neurol 54:790-795, Hess,D.C.,et al, 2000
Clinicopath Conf,Cerebral Amyloid Angiogpathy and Giant-Cell Inflammatory Reaction to Beta 4-Amyloid and Vasculitis, Case 10-2000
NEJM 342:957-965, , 2000
Serum Lipids in Young Patients with Ischaemic Stroke: A Case-control Study
JNNP 69:29-33, Albucher,J.F. et al, 2000
Pravastatin Therapy and The Risk of Stroke
NEJM 343:317-326, White,H.D. et al, 2000
Statins and the Risk of Dementia
Lancet 356:1627-1631, Jick,H.,et al, 2000
Low-Density Lipoprotein Cholesterol and the Risk of Dementia with Stroke
JAMA 282:254-260, Moroney,J.T.,et al, 1999
Is Cholesterol a Risk Factor for Stroke? No
Arch Neurol 56:1521-1524, Landau,W.M., 1999
Is Cholesterol a Risk Factor for Stroke? Yes
Arch Neurol 56:1518-1520,1524, Demchuk,A.M.,et al, 1999
Effect of HMGcoA Reductase Inhibitors on Stroke, A Meta-Analysis of Controlled Trials
Ann Int Med 128:89-95, Bucher,H.C.,et al, 1998
HIV-Protease Inhibitors
NEJM 338:1281-1292, Flexner,C., 1998
Migrainous Visual Accompaniments are not Rare in Late Life:The Framingham Study
Stroke 29:1539-1543, Wijman,C.A.C.,et al, 1998
Stroke Patterns of Internal Carotid Artery Dissection in 40 Patients
Stroke 29:2646-2648, Lucas,C.,et al, 1998
Vascular Effects of Statins in Stroke
Stroke 28:2315-2320, Delanty,N.&Vaughan,C.J., 1997
High-Density Lipoprotein Cholesterol & Risk of Ischemic Stroke Mortality:21-Yr FU of 8586 Men-Israeli Ischemic Heart Dis Study
Stroke 28:83-87, Tanne,D.,et al, 1997
Cumulative Effects of High Cholesterol Levels, High Blood Pressure, & Cigarette Smoking on Carotid Stenosis
NEJM 337:516-522, Wilson,P.W.F.,et al, 1997
Influence of Cholesterol on Survival After Stroke:Retrospective Study
BMJ 314:1584-1588, Dyker,A.G.,et al, 1997
Epidemiology of Stroke
JNNP 61:333-338, Khaw,K.T., 1996
Predictors of Stroke in Middle-Aged Patients with Non-Insulin-Dependent Diabetes
Stroke 27:63-68, Lehto,S.,et al, 1996
Lipids and Stroke
Arch Neurol 53:303-308, Hachinski,V.,et al, 1996
Low Total Serum Cholesterol and Intracerebral Hemorrhagic Stroke:Is the Assoc Confined to Elderly Men
Stroke 27:1993-1998, Iribarren,C.,et al, 1996
Primary Prevention of Stroke
NEJM 333:1392-1400, Bronner,L.L.,et al, 1995
Lipoprotein (a) & Asympt Carotid Art Disease:Evidence of a Prominent Role in the Evol of Advanced Carotid Plaques
Stroke 26:1582-1587, Willeit,J.,et al, 1995
Plasma Concentration of Lipoprotein (a) and the Risk of Future Stroke
JAMA 273:1269-1273, Ridker,P.M.,et al, 1995
Failure of Aspirin Treatment After Stroke
Stroke 25:275-277, Bornstein,N.M.,et al, 1994
Neuropathy Associated with Hyperlipidemia
Neurol 44:2185-2186, McManis,P.G.,et al, 1994
Risk Factors for Cervical Atherosclerosis in patients with Transient Ischemic Attack or Minor Ischemic Stroke
Stroke 24:970-975, Palomaki,H.,et al, 1993
High Serum Lipoprotein (a) Levels Are an Independent Risk Factor for Cerebral Infarction
Stroke 24:965-969, Shintani,S.,et al, 1993
Cholesterol Reduction and the Risk for Stroke in Men, A Meta-Analysis of Randomized, Controlled Trials
Ann Int Med 119:136-145, Atkins,D.,et al, 1993
Serum Lipid Levels During Carbamazepine Medication
Arch Neurol 50:590-593, Isojarvi,J.I.T.,et al, 1993
One-Year Reduction and Longitudinal Analysis of Carotid Intima-Media Thickness Associated with Colestipol/Niacin Therapy
Stroke 24:1779-1783, Mack,W.J.,et al, 1993
Autoantibody Against Oxidised LDL and Progression of Carotid Atherosclerosis
Lancet 339:883-900, Salonen,J.T.,et al, 1992
Antibodies to Oxidised LDL in Atherosclerosis
Editorial, Lancet 339:899-9001992., , 1992
Ticlopidine for Prevention of Stroke
The Medical Letter, 34:65-661992., , 1992
Lioporotein and Apolipoprotein Profile in Men with Ischemic Stroke
Stroke 23:1556-1562, Pedro-Botet,J.,et al, 1992
Serum Cholesterol Concentration and Risk of Primary Brain Tumours
BMJ 302:90, Knekt,P.,et al, 1991
Fibrinogen and Lipid Concentrations as Risk Factors for Transient Ischemic Attacks & Minor Ischaemic Strokes
BMJ 303:605-609, Qizilbash,N.,et al, 1991
Tangier Disease in a Black Patient:An Unusual Clinical Presentation
Am J Med 89:105-108, Lo,W.D.,et al, 1990
Cerebrotendinous Xanthomatosis:Clinical and MRI Study (A Case Report)
JNNP 53:76-78, Fiorelli,M.,et al, 1990
Serum Cholesterol and Hemorrhagic Stroke in the Honolulu Heart Program
Stroke 20:1460-1465, Katsuhiko,Y.,et al, 1989
Atherosclerosis:Current Concepts on Pathogenesis and Interventional Therapies
Ann Neurol 26:3-12, Yatsu,F.M.&Fisher,M., 1989
Plasma Lipoproteins in Cortical Versus Lacunar Infarction
Stroke 20:448-452, Adams,R.J.,et al, 1989
Serum Cholesterol Levels & Six-Year Mortality from Stroke in 350, 977 Men Screened for Multiple Risk Factor Interven Trial
NEJM 320:904-910, Iso,H.,et al, 1989
Plasma Cholesterol Concentration and Primary Brain Tumors
BMJ 299:26-27, Davey,G.,et al, 1989
Prediction of Carotid Stenosis Progression by Lipid & Hematologic Measurements
Neurol 39:1325-1331, Grotta,J.C.,et al, 1989
Relation Between Blood Lipids, Lipoproteins, and Cerebrovascular Atherosclerosis:A Review
Stroke 19:423-430, Tell,G.S.,et al, 1988
Coma as a Presenting Sign of Epstein-Barr Encephalitis
Arch Int Med 148:1459-1461, Demey,H.E.,et al, 1988
Risk of Brain Infarction in Familial Hypercholesterolemia
Stroke 19:1097-1100, Kaste,M.&Koivisto,P., 1988
Hyperlipidemia is a Risk Factor for Decreased Cerebral Perfusion & Stroke
Arch Neurol 44:418-422, Meyer,J.S.,et al, 1987
Prophylaxis of Atherosclerosis with Marine Omega-3 Fatty Acids, A Comprehensive Study
Ann Int Med 107:890-899, VonSchacky,C., 1987
Migraine in Children:Association with Primary & Familial Dyslipoproteinemias
Pediatrics 77:316, Glueck,C.J.&Bates,S.R., 1986